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BRIEF COMMUNICATIONS
Clinically Distinct Codon
69 Mutations in Major
Myelin Protein Zero
in Demyelinating 
Neuropathies
Peter H. S. Meijerink, PhD,* Jessica E. Hoogendijk, 
M D ,f Anneke A. W. M. Gabreëls-Festen, M D ,-t 
Ina Zorn,* Henk Veldman,1' Frank Baas, PhD,* 
Marianne de Visser, MD,* and Pieter A. Bolhuis, PhD*
Mutations in the major peripheral myelin protein zero 
(PO) gene on chromosome Iq21-q23 have been found 
with the hereditary demyelinating polyneuropathy Char­
co t-Marie-Tooth type IB. Here, we describe 2 patients 
with distinct neurological characteristics, carrying differ­
ent substitutions at the saíne codon—Arg69His and Arg- 
69Cys. The patients were heterozygous for the mutation3 
which in both appeared to be de novo. Histological exam­
ination of sural nerve biopsy specimens revealed defective 
myelin as well as marked differences, confirming the im­
portance of PO in the compaction of myelin.
Meijerink PHS, Hoogendijk JE, Gabreëls-Festen 
AAWM, Zorn I, Veldman H, Baas F, de Visser 
M, Bolhuis PA. Clinically distinct codon 69
mutations in major myelin protein zero
in demyelinating neuropathies.
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Charcot-Marie-Tooth type 1 (CMT1 or hereditary 
motor and sensory neuropathy [HMSN] type I) is the 
most frequently inherited, autosomal dominant, demy­
elinating polyneuropathy and appears to be genetically 
heterogeneous [1], The locus for CMT1A, the most 
common form, maps to chromosome 17p 11.2 and is
usually associated with a DNA duplication of 1.5 Mb
encompassing the peripheral myelin protein 22 
(PMP22) gene. Single-base mutations in the PMP22 
gene have been reported in a f
CMT1A cases [1, 2J.
Alterations in the major peripheral myelin protein 
zero (PO) gene, localized on chromosome Iq21-q23, 
have been shown to cause CMT1B [1, 31 and have
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also been found in patients with sporadic early-onset 
disease with a more severe phenotype, also known as
Dejerine-Sottas syndrome [4].
P0 is a 28-kd integral membrane glycoprotein en­
coded by 6 exons. It belongs to the immunoglobulin 
superfamily, having a single extracellular domain re­
sembling the immunoglobulin variable domain. In ad­
dition, P0 contains single transmembrane and cyto­
plasmic domains [5]. A role for P0 in myelin formation 
has been demonstrated by the analysis of mice lacking 
P0 expression due to targeted mutagenesis [6]. Since 
the extracellular domain (encoded by exons 2 and 3) 
is capable of homophilic interaction, P0 presumably 
plays a role in the compaction of peripheral myelin
m.
We performed a mutation screening of the PO gene 
in unrelated CM T patients, already characterized as 
non-CM TlA, by single-stranded conformational anal­
ysis (SSCA) followed by sequencing of the relevant 
DNA region. To study the effect of P0 mutations on 
myelin compaction, we also performed electron micro­
scopic examinations on sural nerve biopsy specimens 
from the patients.
Materials and Methods
Patients
CMT1 patients were identified on the basis of neurological 
abnormalities and markedly reduced nerve conduction. Pa­
tients had already been analyzed for the presence of the 
CMT1A duplication and screened for mutations in the 
PMP22 gene. With informed consent, sural nerve biopsy 
samples were taken from the patients and examined by light 
and electron microscopy.
Patient 1, a 28-year-old woman, had normal early devel­
opment. From the age of 2 years onward, motor perfor­
mances slowly deteriorated. Neurological examination at age 
12 years revealed pes cavus, distal muscular weakness and 
atrophy of the lower legs and the hands, slight distal sensory 
loss, and nearly absent tendon reflexes. Motor nerve conduc­
tion velocity (MNCV) of the median nerve was 19 m/sec. 
Sural nerve biopsy was performed. In the following years her 
condition hardly deteriorated. The patient carried a 
Arg69His substitution in exon 3 of the PO gene (see Results).
Patient 2, a girl, had normal development until the age 
of 6 months. Motor development then stopped and she dete­
riorated after the age of 10 months. At 14 months, she had 
an extreme head lag, had difficulties coughing, choked, and 
cried without sound. She did not roll over nor did she push 
herself up anymore. The arms and legs were weak and flaccid 
with areflexia. Sural nerve biopsy was performed. She died 
at the age of 22 months. M NCV in the ulnar nerve was 8.5 
m/sec. She carried a Arg69Cys substitution in exon 3 of the 
PO gene (see Results).
Mutation Detection
Genomic DNA was isolated from leukocytes according to 
standard procedures. Primers were chosen according to pub-
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lished PO exonic and in tronie sequences [5]: primers (5*—
30— P0ex2Rl CTGAGACCCACTCACTGGAC; P0ex2F2 
AGGTCCATGGTGCTGTGG; P0ex2R2 TTATCGAACC 
CCAGGATTCC; P0ex3Fl AGGGTCCTCTCACATGC 
TTC; P0ex3Rl AG G T T G T  G T AT G ACAAT G G AG C ; and 
P0ex3F2 TG  G C TC  C ATT G T C  AT AC AC A. Primers A to F
described by Hayasaka and colleagues [8] were also used. 
SSCAs were carried out essentially as described by Nicholson 
and coauthors [9]. For analysis of the separate alleles, the 
SSCA fragments were cut out of the gel and eluted in 100 
|il of sterile water. After three cycles of freezing (liquid nitro­
gen) and thawing (65°C), 5 JLll was used in a 50-J.ll standard 
polymerase chain reaction (PCR) for sequencing. PCR prod­
ucts for sequencing were also generated from genomic DNA 
(100 ng). Products were column purified (Qiagen) and 50 ng 
was directly sequenced using the dideoxy chain termination 
method with the Sequitherm Cycle Sequencing Kit (Epi­
centre Technologies) and ^P-end-labeled P0 primers. Sam­
ples were electrophoresed on 7% denaturing polyacrylamide
Nucleotide numbering of P0 starts at the initiation site of 
translation. Amino acid numbering starts at the first amino 
acid (lie) of the mature P0 protein (without the 29 amino 
acids from the signal peptide) [ 10].
Light and Electron Microscopy
Sural ne I've biopsy specimens were prepared for light and 
electron microscopic examination including morphometric 
analysis. For ultrastructural analysis nerve specimens were 
fixed immediately in 2% glutaraldehyde in 0.1 M cacodylate
buffer, pH  7.4, at 4°C for 3 hours and postfixed in 2% 
osmium tetroxide, pH  7.4, for 1 hour, dehydrated in alcohol, 
and embedded in epoxy resin (Epon). More than 1,000 
nerve biopsy specimens were analyzed this way, including 
from more than 100 patients with HM SN [11].
Results
Mutations
We analyzed the PO gene for the presence of mutations 
using SSCA and direct sequencing. Patient 1 carried a 
G-to-A mutation at position 293, leading to an amino 
acid substitution of Arg to His at codon 69 (the same 
mutation was found in another CMT1B patient [12]). 
The Arg69His mutation appeared to be absent from 
exon 3 of both clinically normal parents, demonstrat­
ing the de novo origin of the substitution. Another de 
novo base change (C to T  at position
in the severely affected patient (Patient 2), re­
sulting in an amino acid substitution of Arg by Cys at 
the same codon 69. The patients were heterozygous 
for the mutant and the normal allele. Paternity was 
confirmed for both patients. Furthermore, the entire 
coding region of the PO gene of the patients was se­
quenced and revealed no further mutations.
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Light and Electron Microscopy
Sural nerve biopsy fro m patients
showed a marked reduction in density of myelinated
T O '
p í f
y • ¿ L - 9 '
■A-
.<{
r> . •> . s • '/
,  ■:
.'.i
-4
W
Electron microscopy o f sural nerve specimen from Patient 1 
(Arg69His), age 12 years. Uncompaction o f myelin is seen at 
the inner and outer parts o f the myelin sheath. Dilatation o f 
major dense lines is most pronounced. A t some places, fusion
o f intraperiod lines has occurred (arrow). Bar 1 Urn.
fibers. Patient 1 (Fig 1) had 6,010 and Patient 2 7,200 
fibers/mnr, corresponding to 57% and 46% of the 
age-related values, respectively. In Patient 1, large- 
diameter fibers (>  6.5 f.lm) were totally lacking; most 
fibers were thinly myelinated and surrounded by onion 
bulbs of concentrically arranged Schwann cell lamellae. 
By ultrastructural examination of cross sections, the 
vast majority of fibers (80%) showed uncompacted my­
elin lamellae, which in some cases (>  12%) could not 
be discerned from a Schmidt-Lanter man incisure. The 
uncompacted structure was present over the whole or 
part of the circumference of the fiber and commonly 
involved the inner lamellae, but occasionally the outer 
lamellae as well. Dilatation of the major dense line was 
most pronounced, with often changing amounts o 
Schwann cell cytoplasm in between. Partial fusion of 
intraperiod lines was observed on occasional fibers.
On the other hand, Patient 2 showed only few on­
ion bulbs, clearly coo-thin myelin sheaths in compari­
son with axon diameter, and almost no large fibers (2% 
>  6 |am, 0%) >  8 (.Lm). Increased neurofilamenr accu-
in demyelinated axons. Oninitiation was
cross sections almost half the fibers a
partially uncomp 
often than
structure of lin, much more
-Lanterman incisures were
m
Discussion). About one third of the fibers s 
in figures at the axonal side of the
of early myelin degradation.
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Discussion
PO, the major structural component of peripheral ner- 
volus system myelin, is an integral membrane protein 
and its expression is confined to myelating Schwann 
cells. We screened genomic DNA of CMT1 patients 
for mutations in the coding part of the PO gene and 
demonstrated mutations in both patients. In contrast 
to Patient I, Patient 2 was diagnosed as severely af­
fected with C M T l. Surprisingly, the same exon 3 co­
don in both patients was substituted with different 
amino acids— Arg69His (Patient 1) and Arg69Cys 
(Patient 2). This amino acid is highly conserved among 
many species [10], suggesting that Arg69 plays an im­
portant role in formation and maintenance of the my­
elin sheath. Interestingly, the severely affected CM TlB 
patient described by Hayasaka and colleagues [4] car­
ried a Ser34Cys substitution, suggesting a more dra­
matic effect on the function of P0 when cysteine is 
substituted at certain amino acid positions. Thus far, 
the majority of disease-associated amino acid substitu­
tions in C M TlB  patients have been found in the extra­
cellular domain of PO [1].
Direct binding experiments have shown a major role 
for the P0 extracellular domain in the compaction of 
peripheral myelin [7]. The PO extracellular domain 
contains a nonasaccharide that is N-linked to Asn93 
and two cysteines at positions 21 and 98. Both P0 
molecules in the homophilic pair have to be glycosyl­
ated for adhesion to take place [13]. The cysteines form 
a disulfide bond that is essential to the functioning of 
P0 as an adhesion molecule [14]. The cytoplasmic do­
main of P0 is thought to interact with a component 
of the opposing membrane in compact myelin, thereby 
holding these membranes together at the major dense 
line [15].
Recently, a molecular model of the P0 extracellular 
domain was described [16]. According to this model, 
Arg69 is postulated to be on putative ß-strand 6 of the 
P0 extracellular domain. This residue is predicted to 
be essential for complementary electrostatic interac­
tions from apposed membranes and may also be in­
volved in the protein-carbohydrate interaction at the 
base of the molecule [17]. Substitution of this residue 
with cysteine probably results in inappropriate forma­
tion of either intramolecular or intermolecular disulfide 
bonds, whereas Arg69His most likely leads to disrupted 
P0-P0 interactions through steric hindrance or changes 
in electrostatic interactions, or both, all leading to de­
fective myelin [17]. On the other hand, both muta­
tions also might lead to deleterious conformational 
changes or disrupt the P0 extracellular domain—carbo­
hydrate link.
In support of this hypothesis, the histological exami­
nations of sural nerve biopsy specimens showed defec­
tive compaction of myelin (see Fig). Although in sev­
eral instances the uncompacted myelin structure might
be ascribed to Schmidt-Landerman incisures, the over­
all frequency on cross sections (80% in Patient 1, 43% 
in Patient 2) markedly surpassed the frequency of 
Schmidt-Lanterman incisures in normal sural nerves 
(0-5.5%, n =  3) or in nerves from patients with ge­
netically unspecified, demyelinating HM SN ( ^  9%, n 
= 9) [18]. In both patients wide spacing of myelin 
layers was seen most frequently at the inner layers of 
the sheath. Patient 2 with Arg69Cys showed an in­
crease in neurofilament density of demyelinated axons, 
a feature sometimes seen in demyelinated axons in hu­
man or animal pathology [11, 19]. Family analysis 
showed that both Arg69 substitutions were de novo 
mutations, underlining the role of P0 in the pathogen­
esis of C M TlB .
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Cognitive and Brain 
Magnetic Resonance 
Imaging Findings in
Adrenomyeloneuropathy
David Edwin, PhD,* Lynn J. Speedie, PhD,* 
Wolfgang Kohler, MD,} Sakkubai Naidu, MD,+ 
Bernd Kruse, MD,§ and Plugo W. Moser, M D f
Neuropsychological functioning and brain magnetic 
resonance imaging (MRI) were evaluated in 84 men with 
adrenomyeloneuropathy (AMN). MRI was normal in 
61%, the “pure AMN” group, while 39%, the “cerebral 
AMN” group, showetl brain white matter abnormalities. 
Except for mild deficits in psychomotor speed and visual 
memoiy, neuropsychological function was normal in pure
AMN. Most patients with cerebral AMN had normal IQ
and language but evidenced impaired psychomotor speed, 
spatial cognition, memory, and executive functions. Pa­
tients with MRI evidence of very severe cerebral disease 
had global and language impairment as well, and deficits 
in all patients were highly correlated with degree of brain
MRI involvement.
Edwin D, Speedie LJ, Kohler W, Naidu S, 
Kruse B, Moser HW. Cognitive and brain 
magnetic resonance imaging 
findings in adrenomyeloneuropathy. 
Ann Neurol 1996;40:675-678
X-linked adrenoleukodystrophy (ALD) [1] presents in 
childhood as a rapidly dementing illness with a charac­
teristic pattern of demyelination demonstrable by mag­
netic resonance imaging (MRI) [2]. In adulthood, it 
presents most commonly as a slowly progressive para­
paresis associated with degeneration of the long tracts 
in the spinal cord [2], which is referred to as adreno­
myeloneuropathy (AMN). While, in comparison with 
childhood ALD cerebral function in AMN is well pre­
served, we have shown previously that some AMN pa­
tients develop subcorcical dementia [3], and 45% have 
white matter abnormalities demonstrable by MRI [4]. 
This report correlates neuropsychological function and
brain MRI in AMN patients.
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